Patents Assigned to ELAN Pharmaceuticals, LLC
  • INHIBITORS OF LRRK2 KINASE ACTIVITY
    Publication number: 20160024071
    Abstract: The present invention provides compounds having a structure according to Formula I. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.
    Type: Application
    Filed: March 12, 2014
    Publication date: January 28, 2016
    Applicant: ELAN PHARMACEUTICALS, LLC
    Inventors: Albert GAROFALO, Danielle AUBELE
  • Antibodies to alpha-synuclein
    Patent number: 8673593
    Abstract: The invention provides methods for detecting alpha-synuclein. The invention also identifies preferred epitopes of alpha synuclein for use in such detection, and provides antibodies specifically binding to such epitopes.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: March 18, 2014
    Assignee: ELAN Pharmaceuticals, LLC
    Inventors: Tamie Chilcote, Robin Barbour